ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

19 Years old male with ST elevation myocardial infarction as an initial manifestation of primary antiphospoholipid syndrome

Journal: International Journal of Vascular Surgery and Medicine (Vol.3, No. 3)

Publication Date:

Authors : ; ;

Page : 040-042

Keywords : Antiphospholipid syndrome; Antiphospholipid antibodies; Acute myocardial infarction;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Antiphospholipid antibody syndrome (APS) is a systemic, autoimmune, acquired disorder characterized by venous and/or arterial thrombosis and/or pregnancy morbidities [1]. Although detectable at 1-5% of asymptomatic subjects, persistent antiphospholipid antibodies (aPL) are significantly associated with recurrent arterial/venous thrombosis and pregnancy morbidity [2]. The 2006 International consensus Statement on an Update of the classification criteria recognize those antiphospholipid antibodies (aPLs): lupus anticoagulant (LA), anticardiolipin antibodies (ACA) IgM or IgG and antibody to  2 glycoprotein 1 (-2-GP I) [3]. Those should be confirmed at least two occasions, 12 weeks apart [1]. Primary APS has generally been defined as the presence of aPL in patients with idiopathic thrombosis, but no evidence of autoimmune disease or other inciting factor, such as infection, malignancy, hemodialysis or drug-induced APL.

Last modified: 2018-09-14 14:59:01